Glatiramer acetate
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This article is a stub. |
Copaxone or glatopa, and glatiramer, its generic form, is a drug licensed to reduce relapses in patients with multiple sclerosis.[1]
ME/CFS[edit | edit source]
Ron Davis of the Open Medicine Foundation reports that when the nanoneedle electrical impedance test on ME/CFS cells was used, Copaxone made the cells respond in the same way as healthy cells did, suggesting it is a potential treatment for ME/CFS.[2]
See also[edit | edit source]
Learn more[edit | edit source]
- Copaxone - drugs.com
References[edit | edit source]
- ↑ "Copaxone: Uses, Dosage, Side Effects". Drugs.com. Retrieved April 30, 2019.
- ↑ Davis, Ron (September 2019). "Dr. Ron Davis Presents on ME/CFS Research Activities at Stanford at Inaugural Harvard Symposium". Retrieved September 8, 2019. Cite has empty unknown parameter:
|dead-url=
(help)